Ankylosing Spondylitis (Bekhterev’s Disease) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Ankylosing Spondylitis (Bekhterev’s Disease) – Drugs In Development, 2024 report and make more profitable business decisions.
Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine’s bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.
The Ankylosing Spondylitis (Bekhterev’s Disease) drugs in development market research report provide comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev’s Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev’s Disease) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Ankylosing Spondylitis (Bekhterev's Disease) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 76 molecules, with 75 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Ankylosing Spondylitis (Bekhterev’s Disease) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Ankylosing Spondylitis (Bekhterev’s Disease) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AbbVie IncAccro Bioscience Suzhou Co Ltd
AIxplorerbio Inc
Akeso Inc
Asia Cell Therapeutics (Shanghai) Co Ltd
Asia Stem Cell Regenerative Pharmaceutical Co Ltd
Aurigene Oncology Ltd
Avesthagen Ltd
Beijing Eastern Biotech Co Ltd
Bio-Thera Solutions Ltd
Biocad
Biogen Inc
Bioviz Technologies Pvt Ltd
BioXpress Therapeutics SA
Bristol-Myers Squibb Co
DNX Biopharmaceuticals Inc
Dyadic International Inc
Eli Lilly and Co
ellennbe GmbH
Foshan Rexie Biotechnology Co Ltd
FunPep Co Ltd
Gilead Sciences Inc
Huabo Biopharm (Shanghai) Co Ltd
Hualan Biological Engineering Inc
Iltoo Pharma
Intas Pharmaceuticals Ltd
Izana Bioscience Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
JiangSu Qyuns Therapeutics Co Ltd
Jiangsu Vcare PharmaTech Co Ltd
Johnson & Johnson
JSR Life Sciences LLC
Lanleys International Inc
Livzon Pharmaceutical Group Co Ltd
Lmito Therapeutics Co Ltd
Luye Pharma Group Ltd
Lynk Pharmaceutical Hangzhou Co Ltd
Mabpharm Ltd
Minapharm Pharmaceuticals
MoonLake Immunotherapeutics
Mycenax Biotech Inc
NeuClone Pty Ltd
Nimbus Therapeutics LLC
North China Pharmaceutical Group New Drug Research and Development Co Ltd
Pharmapraxis
PKU V-Ming (Hefei) Biologics Co Ltd
Qilu Pharmaceutical Co Ltd
RheumaGen LLC
Sandoz Group AG
Shandong Danhong Pharmaceutical Co Ltd
Shanghai Junshi Biosciences Co Ltd
Shanghai Novamab Biopharmaceuticals Co Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
Shilpa Biologicals Pvt Ltd
Siam Bioscience Co Ltd
SinoCelltech Group Ltd
Sinopharm Group Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
Tianjin Hemay Pharmaceutical Co Ltd
UCB SA
Valin Technologies Ltd
Wuhan Institute of Biological Products Co Ltd
Yatai Institute of Innovative Medicine
Zhejiang Borui Biopharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Ankylosing Spondylitis (Bekhterev's Disease) reports